Rising Future of Acute Intermittent Porphyria Market

Mon, 10 Feb 2025 09:18:18 +0000

Acute Intermittent Porphyria (AIP) is a rare genetic disease characterized by attacks of severe abdominal pain, vomiting, and neurological abnormalities. The condition results from a deficiency in the enzyme porphobilinogen deaminase (PBGD). Symptoms include severe abdominal pain, nausea or vomiting, constipation, and other neurological symptoms such as delirium, seizures and paralysis.